International Corporate Governance

International Corporate Governance

A Case Study Approach

Edited by Christine A. Mallin

Corporate governance has become a global phenomenon. This book highlights, through various case studies, how corporate governance has evolved in a number of countries around the world. The international cast of contributors, from varying professional backgrounds including academics, lawyers and company directors, focus on different regions around the globe, reflecting various ownership structures, legal systems, and political and cultural aspirations. Some of the case studies used include: Standard Life; Telecom Italia; and Eskom.

Chapter 5: Managerial Reasoning in Takeover Battles: The Case of Sanofi-Synthélabo and Aventis

Axel v. Werder and Till Talaulicar

Subjects: business and management, corporate governance, international business, economics and finance, corporate governance, international business, money and banking, law - academic, corporate law and governance

Extract

Axel v. Werder and Till Talaulicar INTRODUCTION On 26 January 2004 the pharmaceutical company Sanofi-Synthélabo announced an unsolicited tender offer to acquire all of the shares of its competitor Aventis. Based on sales Aventis was twice as large as the bidder. Although both the management board and the supervisory board of Aventis rejected this offer immediately, Sanofi-Synthélabo maintained its attempt to gather control over its competitor. A takeover battle began. It followed an intensive and expensive corporate campaign to gain shareholders’ support for each company’s respective and conflicting strategy. In particular the two companies intended to convince their shareholders and the general public of their respective position. In other words, they were putting forward arguments that gave reasons why their recommendation was preferable and the opposing strategy should be refuted. Eventually Aventis’s top management dismissed its defence. After Sanofi-Synthélabo had filed an improved offer, both the management board and the supervisory board of Aventis agreed to cooperate and recommended their shareholders to accept the new offer. By August 2004 Sanofi-Synthélabo had taken control of more than 95 per cent of Aventis’s shares and voting rights. Thus the offer succeeded. Mergers and acquisitions (M&As) are not an uncommon phenomenon studied from, inter alia, economic (Ghemawat and Ghadar 2000), capital market (Jensen and Ruback 1983), strategic management (Lubatkin and Lane 1996) or organizational behaviour (Jemison and Sitkin 1986) perspectives. Regarding corporate governance, M&As and particularly hostile takeover bids are the most important...

You are not authenticated to view the full text of this chapter or article.

Elgaronline requires a subscription or purchase to access the full text of books or journals. Please login through your library system or with your personal username and password on the homepage.

Non-subscribers can freely search the site, view abstracts/ extracts and download selected front matter and introductory chapters for personal use.

Your library may not have purchased all subject areas. If you are authenticated and think you should have access to this title, please contact your librarian.

Further information